Fibronectin type III domain-containing protein 3B (292-300)

Fibronectin type III domain-containing protein 3B (292-300) is a synthetic peptide fragment derived from a specific region within the fibronectin type III domain-containing protein 3B (FNDC3B). As a member of the fibronectin type III repeat superfamily, this peptide encompasses a sequence that is often implicated in protein-protein interactions, cellular adhesion, and extracellular matrix modulation. Its defined amino acid composition and structural motif make it a valuable molecular tool for dissecting the functional roles of FNDC3B in cellular signaling and matrix biology. Researchers utilize such peptides to explore the mechanistic underpinnings of cell-matrix communication, tissue remodeling, and the regulation of fibronectin-associated pathways in various biological contexts.

Peptide mapping and structural studies: The 292-300 fragment serves as a precise probe for peptide mapping experiments, facilitating the identification of interaction sites within the FNDC3B protein or with its biological partners. By incorporating this peptide into binding assays or structural analyses, investigators can elucidate the molecular determinants of domain-specific interactions, contributing to a deeper understanding of how fibronectin type III domains mediate cellular processes. Its defined sequence enables high-resolution mapping of functional residues involved in protein-protein recognition.

Cell adhesion and migration research: FNDC3B-derived peptides are widely employed in studies investigating the molecular mechanisms underlying cell adhesion and migration. The 292-300 segment can be used to assess its influence on cell attachment to extracellular matrix components, providing insights into how specific fibronectin type III motifs regulate integrin-mediated signaling or cytoskeletal organization. Such applications are particularly relevant in the context of tissue engineering, wound healing, and developmental biology, where cell-matrix interactions are pivotal.

Signal transduction pathway analysis: The peptide fragment representing residues 292-300 is a useful tool for dissecting intracellular signaling cascades initiated by fibronectin type III domain interactions. Researchers can utilize it in in vitro assays to modulate or compete with endogenous FNDC3B activity, thereby clarifying its role in pathways such as focal adhesion kinase activation, MAPK signaling, or other downstream effectors. This approach enables the functional characterization of domain-specific contributions to cellular responses.

Antibody production and epitope mapping: The defined sequence of the 292-300 region makes it an ideal antigen for generating sequence-specific antibodies against FNDC3B. These antibodies can be employed in immunodetection, immunoprecipitation, or immunohistochemistry to localize and quantify the native protein in complex biological samples. Furthermore, the peptide can be used in epitope mapping studies to identify antibody binding sites, supporting the development of highly selective research reagents.

Peptide-based functional assays: Synthetic peptides corresponding to fibronectin type III domain regions are frequently utilized in functional assays to probe the biological activity of the parent protein. The 292-300 fragment can be introduced into cell culture or biochemical systems to assess its effect on processes such as cell spreading, matrix assembly, or receptor engagement. These assays provide critical data on the contribution of specific sequence motifs to the overall function of FNDC3B in extracellular matrix dynamics and cellular physiology.

1. Autoinhibition and phosphorylation-induced activation of phospholipase C-γ isozymes

2. Olfactory receptor based piezoelectric biosensors for detection of alcohols related to food safety applications

3. Immune responses to homocitrulline-and citrulline-containing peptides in rheumatoid arthritis

4. A possible role of tachykinin-related peptide on an immune system activity of mealworm beetle, Tenebrio molitor L

5. The spatiotemporal control of signalling and trafficking of the GLP-1R